Comisar W - Search Results

1

Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants.

Migoya EM, Mistry GC, Stone JA, Comisar W, Sun P, Norcross A, Bi S, Winchell GA, Ghosh K, Uemera N, Deutsch PJ, Wagner JA. Migoya EM, et al. Among authors: comisar w. J Clin Pharmacol. 2011 Feb;51(2):202-11. doi: 10.1177/0091270010374853. Epub 2010 Aug 2. J Clin Pharmacol. 2011. PMID: 20679501 Clinical Trial.

2

Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis.

Comisar W, Sun P, Li S, Sable C, Schwartz M, Bi S, Chow J, Ngai A, Winchell G, Kartsonis N, Stone J. Comisar W, et al. Clin Pharmacol Drug Dev. 2014 Jan;3(1):43-50. doi: 10.1002/cpdd.44. Epub 2013 Jul 5. Clin Pharmacol Drug Dev. 2014. PMID: 27128229

3

A single supratherapeutic dose of vorinostat does not prolong the QTc interval in patients with advanced cancer.

Munster PN, Rubin EH, Van Belle S, Friedman E, Patterson JK, Van Dyck K, Li X, Comisar W, Chodakewitz JA, Wagner JA, Iwamoto M. Munster PN, et al. Among authors: comisar w. Clin Cancer Res. 2009 Nov 15;15(22):7077-84. doi: 10.1158/1078-0432.CCR-09-1214. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887475 Clinical Trial.

4

Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals.

Zhu L, Butterton J, Persson A, Stonier M, Comisar W, Panebianco D, Breidinger S, Zhang J, Bertz R. Zhu L, et al. Among authors: comisar w. Antivir Ther. 2010;15(8):1107-14. doi: 10.3851/IMP1673. Antivir Ther. 2010. PMID: 21149917 Clinical Trial.

5

A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humans.

Cabal A, Mehta K, Ross DS, Shrestha RP, Comisar W, Denker A, Pai SM, Ishikawa T. Cabal A, et al. Among authors: comisar w. J Bone Miner Res. 2013 Aug;28(8):1830-6. doi: 10.1002/jbmr.1900. J Bone Miner Res. 2013. PMID: 23436611 Free article.

6

Integrin organization: linking adhesion ligand nanopatterns with altered cell responses.

Comisar WA, Mooney DJ, Linderman JJ. Comisar WA, et al. J Theor Biol. 2011 Apr 7;274(1):120-30. doi: 10.1016/j.jtbi.2011.01.007. Epub 2011 Jan 19. J Theor Biol. 2011. PMID: 21255586 Free PMC article.

7

Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach.

Comisar WA, Kazmers NH, Mooney DJ, Linderman JJ. Comisar WA, et al. Biomaterials. 2007 Oct;28(30):4409-17. doi: 10.1016/j.biomaterials.2007.06.018. Epub 2007 Jul 9. Biomaterials. 2007. PMID: 17619056

8

Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogels.

Comisar WA, Hsiong SX, Kong HJ, Mooney DJ, Linderman JJ. Comisar WA, et al. Biomaterials. 2006 Apr;27(10):2322-9. doi: 10.1016/j.biomaterials.2005.10.037. Epub 2005 Nov 28. Biomaterials. 2006. PMID: 16316682

9

Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation.

Lee KY, Alsberg E, Hsiong S, Comisar W, Linderman J, Ziff R, Mooney D. Lee KY, et al. Among authors: comisar w. Nano Lett. 2004 Jul 13;4(8):1501-1506. doi: 10.1021/nl0493592. Nano Lett. 2004. PMID: 25067913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters